Wird geladen...
Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer
Immune checkpoint inhibitors (ICI) have been validated as an effective new treatment strategy in several tumoral types including lung cancer. This remarkable shift in the therapeutic paradigm is in large part due to the duration of responses and long-term survival seen with ICI. However, despite thi...
Gespeichert in:
| Veröffentlicht in: | Transl Lung Cancer Res |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
AME Publishing Company
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8264336/ https://ncbi.nlm.nih.gov/pubmed/34295689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-839 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|